3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications

Recent research has shown that the maintenance of relevant liver functions ex vivo requires models in which the cells exhibit an in vivo‐like phenotype, often achieved by reconstitution of appropriate cellular interactions. Multiple different models have been presented that differ in the cells utili...

Full description

Saved in:
Bibliographic Details
Published inBiotechnology journal Vol. 14; no. 7; pp. e1800347 - n/a
Main Authors Lauschke, Volker M., Shafagh, Reza Z., Hendriks, Delilah F. G., Ingelman‐Sundberg, Magnus
Format Journal Article
LanguageEnglish
Published Germany 01.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent research has shown that the maintenance of relevant liver functions ex vivo requires models in which the cells exhibit an in vivo‐like phenotype, often achieved by reconstitution of appropriate cellular interactions. Multiple different models have been presented that differ in the cells utilized, media, and culture conditions. Furthermore, several technologically different approaches have been presented including bioreactors, chips, and plate‐based systems in fluidic or static media constituting of chemically diverse materials. Using such models, the ability to predict drug metabolism, drug toxicity, and liver functionality have increased tremendously as compared to conventional in vitro models in which cells are cultured as 2D monolayers. Here, the authors highlight important considerations for microphysiological systems for primary hepatocyte culture, review current culture paradigms, and discuss their opportunities for studies of drug metabolism, hepatotoxicity, liver biology, and disease. Reconstitution of liver function in vitro requires 3D culture models. Here, the authors review different materials, cells types, and methods used for good reconstitution and the applications of such systems like prediction of drug toxicity and pharmacokinetics, drug interactions, and diseased liver.
ISSN:1860-6768
1860-7314
DOI:10.1002/biot.201800347